BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19355963)

  • 1. Synthetic and natural immunomodulators acting as interferon inducers.
    Silin DS; Lyubomska OV; Ershov FI; Frolov VM; Kutsyna GA
    Curr Pharm Des; 2009; 15(11):1238-47. PubMed ID: 19355963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Russian experience in screening, analysis, and clinical application of novel interferon inducers.
    Tazulakhova EB; Parshina OV; Guseva TS; Ershov FI
    J Interferon Cytokine Res; 2001 Feb; 21(2):65-73. PubMed ID: 11244570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antitumor action of double-stranded interferon inducers (larifan, ridostin) and reaferon in an experiment].
    Barinskiĭ IF; Posevaia TA; Lavrukhina LA; Kosiakova NP
    Vopr Virusol; 1994; 39(4):179-82. PubMed ID: 7998398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of double-stranded RNA and interferon type I on reproduction of cytomegalovirus in human fibroblasts].
    Sokolova TM; Fatkhutdinova NG; Nosik NN
    Biull Eksp Biol Med; 1991 Jul; 112(7):80-3. PubMed ID: 1665359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of interferon inducers on chemically-induced mutagenesis and carcinogenesis].
    Loginova NS; Kinzirskiĭ AS; Parshina OV; Mirskaia EE; Ershov FI
    Vestn Ross Akad Med Nauk; 1996; (3):28-33. PubMed ID: 8672957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ridostin induces transcription of a wide spectrum of interferon genes in human cells.
    Sokolova TM; Shuvalov AN; Telkov MV; Kolodyazhnaya LV; Ershov FI
    Bull Exp Biol Med; 2013 Dec; 156(2):213-6. PubMed ID: 24319751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the effectiveness of recombinant alpha2-interferon and its inducers in primates with orthopoxvirus infection].
    Loginova SIa; Bogatikov GV; Prikhod'ko AV; Polozov AI
    Vopr Virusol; 1997; 42(4):186-8. PubMed ID: 9304302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cytokine mRNAs by interferon and interferon inducers.
    Vershinina MY; Narovlyansky AN; Deryabin PG; Amchenkova AM; Ivanova AM; Scherbenko VE; Nagurskaya EV; Bechalo VA; Timofeeva TY; Sanin AV; Ershov FI
    Russ J Immunol; 2002 Jul; 7(2):161-6. PubMed ID: 12687259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology and toxicology of the interferons: an overview.
    Mannering GJ; Deloria LB
    Annu Rev Pharmacol Toxicol; 1986; 26():455-515. PubMed ID: 2424363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxicity estimation of unspecific medicinal antiviral agents for prophylaxis and therapy of hazard and especially hazard viral infections].
    Loginova SIa; Borisevich SV; Maksimov VA; Bondarev VP
    Antibiot Khimioter; 2009; 54(3-4):11-4. PubMed ID: 19711842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The inhibiting action of interferon inducers on the multiplication of the human immunodeficiency virus].
    Nosik NN; Nosik DN; Kuznetsova NV
    Vopr Virusol; 1992; 37(2):92-4. PubMed ID: 1441434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cycloferon: mechanism of action, functions and application].
    Bazhanova ED
    Eksp Klin Farmakol; 2012; 75(7):40-4. PubMed ID: 23025052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon inducers: new generation of immunomodulators].
    Ershov FI; Tazulakhova EB
    Vestn Ross Akad Med Nauk; 1999; (4):52-6. PubMed ID: 10377886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon system in women with genital papillomavirus infection receiving immunomodulatory therapy.
    Rogovskaya SI; Zhdanov AV; Loginova NS; Faizullin LZ; Prilepskaya VN; Van'ko LV; Sukhikh GT
    Bull Exp Biol Med; 2002 Nov; 134(5):463-6. PubMed ID: 12802453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inducers].
    Romantsov MG; Ershov FI; Kovalenko AL; Belova OG
    Ter Arkh; 2014; 86(1):83-8. PubMed ID: 24754075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The medical significance of interferons and their inducers].
    Ershov FI
    Vestn Ross Akad Med Nauk; 2004; (2):9-13. PubMed ID: 15101201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of the interferon inducers ridostin and camedon in prevention and treatment of experimental alpha- and flavivirus infections].
    Barinskiĭ IF; Davydova AA; Gribencha SV; Lazarenko AA
    Vopr Virusol; 1996; 41(3):133-5. PubMed ID: 8928508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of interferons in the socially important human viral diseases].
    Ospel'nikova TP
    Vopr Virusol; 2013; 58(5):4-10. PubMed ID: 24640164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The interferon inducer neovir (kamedon) in the combined treatment of chronic inflammatory diseases of the adnexa uteri of chlamydial etiology (a clinical electron-microscopic study)].
    Delektorskiĭ VV; Malinovskaia VV; Strizhakov AN; Iashkova GN; Kagramanova ZhA; Genkin DD; Parfenov VV; Galiautdinov DSh; Balandin AN; Lebedeva TV
    Antibiot Khimioter; 1995 May; 40(5):42-7. PubMed ID: 8534181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological response modifier-mediated resistance to herpesvirus infections requires induction of alpha/beta interferon.
    Kunder SC; Kelly KM; Morahan PS
    Antiviral Res; 1993 Jun; 21(2):129-39. PubMed ID: 7687839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.